The Murmur Pod

How Top LAAO Programs Scale Faster: Efficiency, Workflow, and Growth Strategies

Building a successful LAAO program requires more than procedural skill — it depends on workflow efficiency, team coordination, and scalable systems. In this MurmurMD discussion, Dr. Vijay Iyer and Dr. Joe Walsh break down the key drivers behind LAAO program efficiency and growth, focusing on how high-performing programs optimize patient flow, referrals, procedural planning, and long-term expansion. Key discussion points from the transcript include: • Improving workflow efficiency in LAAO programs • Referral pathways and program growth strategies • Streamlining patient evaluation and scheduling • Building coordination across the heart team • Procedural efficiency and lab workflow optimization • Managing follow-up and longitudinal patient care • Identifying bottlenecks that slow program growth • Lessons learned from scaling successful LAAO programs This discussion provides practical insights into how structural heart teams can grow LAAO programs while improving efficiency and patient care. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why LAAO program efficiency matters 01:30 – Referral pathways and program growth 03:30 – Streamlining workflow and patient evaluation 05:30 – Team coordination and procedural efficiency 07:30 – Managing follow-up and long-term care 09:00 – Lessons learned from scaling LAAO programs #LAAO #StructuralHeart #Watchman #LeftAtrialAppendageClosure #ProgramGrowth #HeartTeam #InterventionalCardiology #MurmurMD

Real-World Reintervention Rates Among TAVR Low-Risk Medicare Patients with Dr. Robert Yeh and Dr. Matthew Summers

As TAVR expands into younger and lower-risk patients, one question continues to drive decision-making: how durable are transcatheter valves over time? In this MurmurMD discussion, Dr. Robert W. Yeh reviews his late-breaker at CRT26, the Evolut valve durability data, focusing on long-term outcomes and what they mean for real-world clinical practice with Dr. Matthew Summers. Key insights from the transcript include: • Long-term performance of self-expanding Evolut valves • How durability is assessed and measured over time • Structural valve degeneration and clinical relevance • Comparing durability expectations in TAVR vs surgical valves • Patient selection and lifetime management considerations • What durability data means for younger TAVR patients • How evolving evidence may shape future practice This discussion provides a focused look at how durability data is influencing TAVR decision-making today and into the future. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why valve durability matters in TAVR 01:00 – Overview of Evolut durability data 02:30 – Structural valve degeneration and outcomes 04:30 – Comparing TAVR vs surgical durability 06:00 – Clinical implications for patient selection 07:30 – Key takeaways and future direction #TAVR #Evolut #ValveDurability #StructuralHeart #AorticStenosis #InterventionalCardiology #MurmurMD

When PCI Gets Dangerous: How LV Support Changes High-Risk Cases

High-risk PCI isn’t just about technique — it’s about protecting the patient while you fix the artery. In this MurmurMD discussion, Dr. Chris Brown and Dr. Yousif Ahmad walk through the role of left ventricular (LV) support in complex PCI, focusing on when to escalate, how to think about hemodynamics, and why support can change the entire strategy. Key insights from the discussion include: • Identifying patients who qualify as high-risk PCI • Recognizing when hemodynamics may deteriorate during intervention • Deciding when to use LV support devices • How support changes procedural planning and execution • Balancing complete revascularization with patient stability • Real-time decision-making during complex cases • Lessons learned from managing high-risk coronary interventions This discussion highlights a critical shift in mindset: in high-risk PCI, success depends as much on support strategy as it does on technical skill. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – What defines high-risk PCI 01:00 – Hemodynamic risk and patient selection 02:30 – When to escalate to LV support 04:00 – How support changes PCI strategy 06:00 – Procedural decision-making under support 07:30 – Outcomes and key takeaways #HighRiskPCI #LVSupport #ComplexPCI #MechanicalCirculatorySupport #InterventionalCardiology #CathLab #MurmurMD

Champion AF Explained: Can LAA Closure Beat DOACs? Ft. Dr. Saibal Kar and Dr. Tom Waggoner

The Champion AF trial is one of the most important studies in structural heart — directly comparing left atrial appendage closure (LAAC) to DOAC therapy in patients with atrial fibrillation. In this MurmurMD discussion, Dr. Saibal Kar and Dr. Thomas Waggoner break down the Champion AF data, focusing on what the results actually mean for clinical practice and how they may shift long-term management strategies. Key themes from the transcript include: • The rationale behind comparing LAAC to DOAC therapy • Trial design and patient population • Key outcomes and how to interpret them • Safety and efficacy considerations • Where LAAC fits in the treatment algorithm today • How these results may impact future guidelines and patient selection This discussion offers a practical, real-world interpretation of a pivotal trial — and what it means for stroke prevention in atrial fibrillation moving forward. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Overview of Champion AF and why it matters 01:00 – Trial design and patient selection 03:00 – Key outcomes and results interpretation 05:30 – Safety and procedural considerations 07:00 – LAAC vs DOAC: how to think about it clinically 08:30 – What this means for practice and future direction #ChampionAF #LAAClosure #AtrialFibrillation #StrokePrevention #StructuralHeart #Watchman #InterventionalCardiology #MurmurMD

Stent Thrombosis Management: IVUS-Guided Strategy and When to Use DCB

Stent thrombosis is one of the most high-stakes complications in PCI — and getting the mechanism right is everything. In this MurmurMD case discussion, Dr. Nyal Borges and Dr. Joe Walsh walk through a real-world case of stent thrombosis, focusing on how intravascular imaging (IVUS) guides diagnosis and how drug-coated balloons (DCB) fit into the treatment strategy. Key discussion points from the transcript include: • Identifying the underlying cause of stent thrombosis • Why angiography alone is insufficient in these cases • Using IVUS to detect under-expansion, malapposition, or mechanical issues • Stepwise management of thrombus and lesion preparation • When additional stenting may worsen outcomes • The role of DCB in avoiding further metal layers • Optimizing vessel expansion before definitive therapy • Real-time decision making during a complex thrombotic case This discussion highlights a critical principle: stent thrombosis is not just treated — it is diagnosed and corrected with imaging. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Case introduction: stent thrombosis presentation 00:40 – Initial angiographic findings 01:20 – Why imaging is critical in stent thrombosis 02:10 – IVUS assessment and identifying the mechanism 03:10 – Lesion preparation and thrombus management 04:10 – Deciding against additional stenting 05:00 – Role of DCB in treatment strategy 05:50 – Final optimization and imaging confirmation 06:30 – Key lessons for managing stent thrombosis #StentThrombosis #IVUS #DCB #ComplexPCI #InterventionalCardiology #CathLab #CoronaryIntervention #MurmurMD